Bioforce AG   Report issue

For profit Phase 3 Phase 4
Founded: Roggwil Switzerland (1963)
Status: No NME R&D (1963)

Organization Overview

First Clinical Trial
2006
NCT00707902
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Bioforce AG